To increase our understanding of chemoattractant One of the first examples of target-derived chemoatmechanisms, we sought to determine the molecular tractants was provided by Lumsden and Davies (1983) identity of Maxillary Factor, using the in vitro collagen gel assay described previously for this factor (Lumsden and Davies, 1983). Using this approach, we have identi-
Figure 1. Developmental Stage Dependence of Maxillary Factor Activity Neurofilament staining (NF-M) of whole mouse embryo heads at the developmental stages relevant to primary trigeminal axon outgrowth (stages 16-20 [A, D, G, J, and M]). Maxillary Factor assays at these stages were performed in the absence (B, E, H, K, and N) or presence (C, F, I, L, and O) of function-blocking antibodies to NGF. As annotated at stage 18 (G-I), trigeminal sensory axons project to their epithelial targets in three branches (ophthalmic [op], maxillary [mx], and mandibular [md]), and chemotropic activity of the maxillary process was assayed by coculturing trigeminal ganglia (TG) and maxillary process tissue in three-dimensional collagen gel matrices for 48 hr. The resulting axonal outgrowth was visualized by staining with the anti-neurofilament antibody NF-M. Activity in the absence of antibody (B, E, H, K, and N) reflects both Maxillary Factor and NGF activity. Activity in the presence of anti-NGF (C, F, I, L, and O) reflects the activity of Maxillary Factor (by definition; Lumsden and Davies, 1983). Maxillary Factor activity was first detectable at stage 16 (B and C), when the first trigeminal axons begin to invade the maxillary and mandibular processes (A). The activity is strongest during stage 18 (G-I), as the first axons arrive at their target epithelium, and the responsiveness and production of NGF has just begun. Activity disappears by stage 20 (M-O)
, when the majority of trigeminal axons have arrived at their target epithelium; at that stage, all of the chemotropic activity of the maxillary process is due to NGF. Scale bar, 250 m. minor components of this activity, respectively. Interestcourse of development of the three peripheral branches of the trigeminal ganglion (ophthalmic, maxillary, and ingly, these factors are made by both the target epithelium and the pathway mesenchyme of the maxillary and mandibular) in the mouse has been described in detail Lumsden, 1984, 1986; Theiler, 1989) and is mandibular processes. We show that the previous observation that Maxillary Factor is expressed by the epishown in Figures 1A, 1D , 1G, 1J, and 1M. The ganglion first becomes discernible around embryonic day 9.5 thelium but not the mesenchyme 1200 fibers extend into the maxillary process at E10.5 (stage 17), with the first fibers reaching the target epitheOur results show that these neurotrophins can be chemoattractants for developing sensory axons. Howlium sometime during E11 (stage 18). Trigeminal axons begin innervating the differentiating whisker follicles ever, their presence in both target and pathway suggests that they are not likely to provide a directional cue around E13 (stages 20-21). The period of naturally occurring cell death in the trigeminal ganglion also starts to instruct the initial migration into the maxillary process. Consistent with this, the initial trajectory of trigeminal around E13. In the assay for Maxillary Factor, trigeminal ganglia axons to their targets in mice deficient in both NT-3 and BDNF is apparently normal, although the possibility of explanted from embryos of stages 16-20 are cultured in three-dimensional collagen gel matrices together with targeting errors at later stages is not excluded. The widespread distribution of NT-3 and BDNF may reflect explants of either the target maxillary process or the target mandibular process taken from the same stage a trophic role for these factors, for which evidence has already been provided (reviewed by Reichardt and Fari- (Lumsden and Davies, 1983) . We have focused most of our studies on guidance to the maxillary process and nas, 1997).
have verified the conclusions of Lumdsen and Davies (1983 . As described, when trigeminal ganglia are Results cultured with target maxillary processes, profuse and directed outgrowth of neurites elicited by the ganglia is Stage Specificity of Maxillary Factor Activity As a first step toward identifying Maxillary Factor, we directed toward the target ( Figures 1B, 1E, 1H, 1K, and  1N ). The effect appeared to be somewhat more robust reproduced the in vitro assay previously used to define and characterize this activity in the mouse. The time in our hands, since we saw outgrowth in essentially 100% of the cases, compared with the ‫%36-%45ف‬ rate been identified at the time those experiments were performed, and their involvement had not been tested. Later (depending on age) previously reported (Lumsden and Davies, 1983, 1986 Figures 1C, 1F, 1I, 1L , and 1O). Our results therefore ble involvement of these factors was our finding that, unlike NGF, mRNA for each of the other three neurofully support the conclusions of Lumsden and Davies (1983, 1986 ) that during the period of trigeminal axon trophins is present in the epithelium of the maxillary process tissue at stage 17, when trigeminal axons are growth to the target, the chemotropic activity of the target is due to a factor, Maxillary Factor, that is distinct navigating to their target epithelia ( Figures 2F-2I ). In addition, however, mRNA for BDNF and NT-3 was also from NGF and that after arrival of the axons, Maxillary Factor activity is downregulated, while the contribution found in the mesenchyme of the maxillary process at stage 17 ( Figures 2F and 2G ), which appears at odds of NGF increases. Maxillary Factor is therefore a candidate for attracting the axons during their initial growth with the description of Maxillary Factor activity as being purely epithelial in origin . to the target.
Neurotrophins Are Candidates for Maxillary Factor
NT-3 and BDNF Account for Maxillary Factor Activity In Vitro Although NGF had been excluded as a candidate for Maxillary Factor, the other members of the neurotrophin To test directly whether BDNF, NT-3, and NT-4/5 contribute to Maxillary Factor activity in the in vitro coculture family of molecules (BDNF, NT-3, and NT-4/5) had not assay, we made use of a number of available functionon neurotrophins by virtue of their ability to bind these factors (Shelton et al., 1995) . Control experiments with blocking reagents against the neurotrophin molecules and of mice carrying inactivating mutations in each of these reagents on stage 17 or 18 trigeminal ganglia cultured with neurotrophins (used at 10 ng/ml) demonthe neurotrophin genes.
We first challenged the outgrowth promoted by stage strated that 1 g/ml TrkA-Fc completely and selectively blocked outgrowth in response to NGF but not the other 17 or 18 maxillary process tissue with highly specific neutralizing antisera directed against either BDNF or neurotrophins, and 1 g/ml TrkC-Fc completely and selectively blocked outgrowth in response to NT-3 but NT-3 (Ghosh et al., 1994; Cohen-Cory and Fraser, 1995). In control experiments, we found that each antiserum not the other neurotrophins. TrkB-Fc demonstrated a broader specificity, with 1 g/ml blocking outgrowth in was, as expected from its previous characterization (Ghosh et al., 1994 ; Cohen-Cory and Fraser, 1995), highly response to 10 ng/ml of either BDNF or NT-4/5 completely and also blocking outgrowth in response to 2.5 specific in neutralizing the outgrowth-promoting activity of its particular antigen (10 ng/ml BDNF or NT-3, respecng/ml NT-3 completely, but to 10 ng/ml NT-3, only partially (data not shown). The broader specificity of TrkB-Fc tively) and did not inhibit the effects of the three neurotrophins that were not its specific antigen (also used at is expected, since TrkB binds BDNF and NT-4/5 with high affinity and NT-3 with lower affinity (Shelton et al., 10 ng/ml; data not shown). When added to cocultures of stage 17 or 18 trigeminal ganglia and maxillary pro-1995). When these Trk-Fc fusion proteins were incubated with stage 17 (or stage 18; data not shown) culcesses, the antiserum specific for NT-3 blocked the majority but not all of the Maxillary Factor activity (n ϭ 10, tures of trigeminal ganglia and maxillary process tissue, TrkB-Fc (1 g/ml) completely blocked Maxillary Factor p Ͻ 0.001; Figures 3C and 3E ). The antiserum to BDNF appeared to have a more modest effect on its own (n ϭ activity (n ϭ 11, p Ͻ 0.001), whereas TrkC-Fc (1 g/ml) consistently blocked the majority but not all of the activ-10, p ϭ 0.002; Figures 3B and 3E ). However, when this antiserum was used in combination with the NT-3 antiseity (n ϭ 11, p Ͻ 0.001; Figures 3H-3J). As expected, TrkA-Fc (1 g/ml) had no effect on Maxillary Factor rum, Maxillary Factor activity was essentially completely blocked (n ϭ 10, p Ͻ 0.001; Figures Figures 5D-5F and 5J-5L) .
glion. In the maxillary process, NT-3 expression increases relative to BDNF expression between stages However, NT-3 expression was significantly stronger in the posterior maxillary mesenchyme and the proximal 16 and 18, suggesting that BDNF might play a more prominent role at earlier stages. In the mandibular mandibular and hyoid processes relative to the anterior maxillary or ophthalmic pathway mesenchyme (Figures process, NT-3 appears significantly more abundant than BDNF at all stages, suggesting that it might account for 5F and 5K, and compare Figures 5D and 5E ). NT-3 Lumsden and Davies (1986) had previously used the The finding that Maxillary Factor is composed of BDNF and NT-3 was puzzling in light of the previously reported hyoid process, an adjoining cutaneous target tissue not normally innervated by trigeminal axons, as a nonspeepithelial specificity of Maxillary Factor activity (Lumsden and Davies, 1986). In those experiments, coculture cific control tissue and had described the hyoid process as being devoid of activity. Another apparent paradox of isolated first branchial arch epithelium or mesenchyme with trigeminal ganglia resulted in axonal outwas therefore raised by our initial finding that NT-3 mRNA is expressed in the hyoid process. However, in growth directed only toward epithelial tissue and never toward mesenchyme. The finding that BDNF and NT-3 transverse sections, we observed a gradient of NT-3 transcripts, high in the proximal portion and very low in are expressed in the mesenchyme at similar or greater levels than in the epithelium did not readily fit with those the distal portion of the hyoid process ( Figures 6C and  6D) . Consistent with this observation, we found that, at observations. We therefore sought to repeat those experiments, stage 17, explants of the proximal hyoid, but not the distal hyoid (n ϭ 10, Figures 6A and 6E; n ϭ 10, p ϭ which involved digesting maxillary process tissue with a protease, such as trypsin, pancreatin, or dispase and 0.01, Figures 6B and 6E) , could elicit outgrowth of axons from trigeminal ganglia, albeit at a low level. These findseparating the epithelium from the mesenchyme prior to culture with the trigeminal ganglion. When we attempted ings therefore resolve the paradox, as Lumsden and 
and [B] with [C] and [D]). As illustrated in (F), in such experiments a portion of the epithelial tissue often becomes necrotic, with the remainder surviving the culture period. (G-I). The expression of NT-3 and BDNF mRNAs in whole stage 18 first branchial arch tissue (squares) or in isolated first branchial arch mesenchyme (circles) was quantified by competitive RT-PCR, using freshly isolated tissue or tissue that had been cultured for 24 hr as described above. Plots of the ratio of competitor product to endogenous cDNA product as a function of the number of molecules of added competitor are shown for NT-3 (G), BDNF (H), and ␤-actin (I). The plot in (G) indicates a 45-fold decrease in absolute NT
-3 mRNA levels in cultured first arch mesenchyme compared with cultured whole first arch tissue. After normalization to the levels of ␤-actin in the tissues (I), a 17-fold decrease in NT-3 levels is observed. This effect is not due to the presence of the epithelial tissue, since a 15-fold decrease in NT-3 levels (after normalization) was observed in cultured mesenchyme relative to the level in freshly isolated mesenchyme (data not shown). BDNF mRNA levels (normalized to ␤-actin levels) in first arch mesenchyme appear to decrease slightly upon culture compared with cultured whole first arch tissue (1.4-fold [H]) or freshly isolated mesenchyme (2.5-fold; data not shown). In an independent experiment, NT-3 and BDNF levels in the mesenchyme decreased 16-fold and 2.6-fold relative to whole first arch tissue (data not shown). Thus, mesenchymal expression of NT-3, but not BDNF, mRNA appears to be maintained by interactions with the epithelium. Scale bar, 200 m (A-F). such separations, under conditions in which the epitheremained contaminated with a layer of mesenchyme during the dissociation procedure (data not shown). This lium and mesenchyme were cleanly separated, to our surprise we found that neither tissue had activity in the raised the possibility that an interaction between epithelium and mesenchyme may be required to maintain the assay. This did not appear to result from some nonspecific action of the proteases, since in control experiexpression of Maxillary Factor activity (i.e., NT-3 and BDNF) during the culture period. ments in which maxillary process tissue was treated with protease but the epithelium and mesenchyme were To test this hypothesis, we took advantage of the fact that the targeting construct used to inactivate the NT-3 left in contact, we observed the expected Maxillary Factor activity (data not shown).
allele in the NT-3-deficient mice directed expression of ␤-galactosidase under control of the NT-3 promoter It is not certain what accounts for the difference between our results and those of previous investigators.
region . When whole maxillary or mandibular processes (stage 18) were cultured for 24 It is possible that they were better able to maintain the health and integrity of the isolated tissues than we were hr (one half of the standard culture period), the expression of ␤-galactosidase was maintained in the tissue (see below). It is also worth noting that the apparent discrepancy may not be as great as it seems, since (compare Figures 7A and 7B ; the effect is illustrated here for experiments using mandibular process tissue although they reported growth exclusively toward the isolated epithelium, outgrowth was observed only in because of the high level of NT-3 expression in that tissue, but maxillary process tissue gave identical re-28% of such cocultures at E11 and in 15% at E10 (Lumsden and Davies, 1986).
sults; data not shown). In contrast, when the isolated epithelium or mesenchyme from enzymatically digested In addition, in the course of these experiments, we found a clue as to why activity was lost in the tissues, tissue was cultured for 24 hr, ␤-galactosidase expression was routinely lost (compare Figures 7C and 7E with at least in our hands. Although we never observed outgrowth toward isolated mesenchyme under any circum- Figures 7D and 7F) . These results were quantified by quantitative RT-PCR using wild-type tissue. An ‫-61ف‬ stances, we did observe that outgrowth occurred toward isolated epithelium in cases in which the epithelium fold reduction in NT-3 expression (relative to ␤-actin; The absence of detectable activity is, however, likely to be explained by the fact that NT-3 and BDNF appears normal. While a direct role for neurotrophins in the initial guidance of trigeminal the intact maxillary process increases in size during culture, whereas the isolated maxillary process does not, sensory axons into the maxillary process in vivo seems unlikely, these factors might nonetheless promote or and even shows a small degree of cell death (Figure 7 ; data not shown), presumably due to the existence of reinforce the growth of these axons into trigeminal target tissues. Our results also do not exclude a possible tropic proliferative and survival signals in the epithelium for the mesenchyme. As a consequence, the absolute amount role for these factors at later stages.
of BDNF expressed by cultured isolated mesenchyme is less than that in cultured intact maxillary processes Resolution of Apparent Discrepancies between ( Figure 7H ) and is presumably below threshold for detecSites of Expression of Maxillary tion in the assay. Indeed, analysis of BDNF ϩ/Ϫ and Factor and of Neurotrophins BDNF Ϫ/Ϫ embryos showed that a 2-fold decrease in Previous studies (Lumsden and Davies, 1983) identified BDNF expression eliminates detectable BDNF activity, Maxillary Factor as an in vitro chemotropic guidance consistent with BDNF expression being at threshold for activity for trigeminal sensory axons that is active during detection (see Results). the primary stages of axon outgrowth and immunologi-A minor difference between our study and that of cally distinct from NGF. We have verified these concluLumsden and Davies (1986) is that they observed some sions and used this in vitro assay to identify Maxillary Maxillary Factor activity in isolated epithelium, whereas Factor activity in the maxillary process as NT-3 (the we did not, except in a few cases in which a layer of major component) and BDNF (the minor component).
mesenchyme remained attached to the epithelium. It is This identification was initially surprising because of the possible that these authors used larger pieces of epithereported epithelial specificity of the activity (Lumsden lium or that their culture conditions were better able to and Davies, 1986), which contrasts with the distribution support the growth of the epithelium or its expression of of the factors. Previous studies analyzing the expression neurotrophins. Indeed, they observed Maxillary Factor of these molecules by in situ hybridization (Arumae et activity in only a minority (28%) of isolated epithelia, and al., 1993) and Northern blot (Buchman and they also noted that activity was seen more frequently observed both BDNF and NT-3 expressed strongly in when the epithelium contacted the plastic substrate and the mesenchyme of first branchial arch tissues. We have flattened out , consistent confirmed and extended these conclusions by showing with the idea that the level of Maxillary Factor activity that NT-3, NT-4/5, and BDNF mRNAs are expressed in was around threshold for detection in the assay and was the epithelium, and NT-3 and BDNF mRNAs are exdependent on precise details of the culture conditions. pressed in the mesenchyme of the branchial arches at A further apparent discrepancy is that NT-3 is also all stages of the growth of trigeminal sensory axons to expressed in the second branchial arch (or hyoid protheir targets. While these in situ hybridization studies cess; Buchman and Davies, 1993; Figure 6 ), whereas demonstrate the mesenchymal expression of these facMaxillary Factor activity was not detected in this tissue tors, the epithelial specificity of Maxillary Factor expres- ). However, NT-3 expression sion was concluded from in vitro culture of isolated in the hyoid process, as in the mandibular arch, is origimaxillary epithelium and mesenchyme with trigeminal nally concentrated in the proximal portion of the hyoid. ganglia, in which trigeminal axons were observed to When proximal versus distal portions of the process grow toward the epithelium but never the mesenchyme were tested for Maxillary Factor activity at early stages .
(stage 17), activity was found only in the proximal tissue. This apparent discrepancy is explained by our finding Lumsden and Davies (1986) ;NT-4/5 Ϫ/Ϫ animals, one would predict, if anyCurrently, the factors that direct the branch-specific thing, the presence of a neurotrophin countergradient, guidance of trigeminal sensory axons are unknown. In higher in the mesenchyme than the epithelium. The abthe presence of function-blocking reagents for BDNF sence of observable defects in these animals thus again and NT-3, no outgrowth is observed toward the maxillary argues against an involvement of neurotrophins in proprocess, and thus, there is no evidence at present for viding guidance information to direct axons to the epithe existence of an additional chemoattractant made by thelium.
the maxillary process. One caveat to this conclusion is One caveat to this conclusion is that we cannot exthat such a chemoattractant might exist, but may have clude the presence of subtle defects not detectable with eluded detection, if it is dependent for its expression or the general axonal marker (anti-neurofilament) used to action on the presence of neurotrophins. Further studies label axons here. In addition, even if the major role of will be required to determine (1) whether there is in fact neurotrophins is to promote growth in each of the three another nonneurotrophin chemoattractant and (2) mains, however, to be determined.
